gettyKey FactsOxford University has begun searching for participants in the early-stage trial, the Financial Times reported Thursday, which will take around four months to complete and could begin as early as next week. MailOnline has approached Oxford University and AstraZeneca for comment. The early-stage trial will enroll adults aged 18 to 40 from the Oxford area, and researchers will conduct four months of follow-up, according to a release posted Thursday. Forbes has reached out to AstraZeneca and Oxford for comment. All participants will receive one dose of the vaccine, with half set to receive a booster dose at a later point in time.
Anyone can be a participant in this trial.
( z0 possible :ARG1 ( z1 participate :ARG0 ( z2 anyone ) :ARG1 ( z3 try :mod ( z4 this ) ) ) )
(z0 / possible-01
    :ARG1 (z1 / participate-01
              :ARG0 (z2 / anyone)
              :ARG1 (z3 / try-02
                        :mod (z4 / this))))
Anyone can be a participant in this trial .
z0 :ARG1 z1
z1 :ARG0 z2
z3 :mod z4
z1 :ARG1 z3